Pricing

Log inSign up

IN8Bio

1 follower

‌

IN8bio, Inc. (“IN8bio”) is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Industries

Biotechnology, Health Care

Headquarters

Birmingham, United States

Employees

11-50

Links

Org chart

William Ho
Director, President, CEO & Co-Founder
Collapse
Kate Rochlin
COO
Pat McCall
CFO
Lawrence Lamb
EVP, Chief Scientific Officer & Co-Founder
SB
Stacey Bilinski
Vice President Clinical Operations
Stacey Bilinski
VP, Clinical Operations
PM
Patrick McCall
Chief Financial Officer
Kate Rochlin
Chief Operating Officer
Corinne Epperly
Board Member

Board & advisors

Alan S. Roemer
Chairman
Peter Brandt
Director
Travis Whitfill
Director
Emily Fairbairn
Director
Bianca Santomasso
Advisor
Bruce Levine
Advisor
Dieter Kabelitz
Advisor
Marcela Maus
Advisor
Siraj Ali
Advisor
Michael Bishop
Advisor
Jeremy R. Graff
Director

Teams

Leadership Team

4 people · 0 jobs

BW
CL

Medical and Technical Roles

3 people · 0 jobs

Offices

Similar companies

Tango Therapeutics

3 followers

Merck

277 followers

Cellares

4 followers

Amgen

273 followers

Function Health

10 followers

Revvity

8 followers

AtriCure

4 followers

Abbott

372 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Explore companies